Home
  >  
Section 12
  >  
Chapter 11,505

The enhancing role of complement in human immunodeficiency virus infection: Soluble recombinant CR1 (CD35) inhibits complement-mediated enhancement of infection of a CD4-positive T-cell line with human immunodeficiency virus-1

Delibrias, C.C.; Fischer, E.M.; Kazatchkine, M.D.

Scandinavian Journal of Immunology 51(5): 526-529

2000

ISSN/ISBN: 0300-9475
PMID: 10792846
DOI: 10.1046/j.1365-3083.2000.00715.x
Accession: 011504167
Download citation:  
Text
  |  
BibTeX
  |  
RIS
The present study investigated the effect of soluble recombinant CR1 (srCR1, sCD35) on complement-dependent enhancement of human immunodeficiency virus-1 (HIV-1) infection in vitro. Cells of the human T-cell line HPB-ALL were infected with HIV-1 that had been preopsonized with normal human HIV-seronegative serum in the presence of srCR1. At nanomolar concentrations, srCR1 suppressed complement-dependent enhancement of infection of HPB-ALL cells in a dose-dependent manner. Under these conditions, infection was decreased to levels similar to those observed in cells infected with unopsonized virus. These observations provide further evidence to support the role of complement-dependent opsonization facilitating viral entry into target cells.

PDF emailed within 0-6 h: $19.90




Related References

Gras, G.S.; Dormont, D. 1991: Antibody-dependent and antibody-independent complement-mediated enhancement of human immunodeficiency virus type 1 infection in a human, Epstein-Barr virus-transformed B-lymphocytic cell line Journal of Virology 65(1): 541-545
Gras, G.; Beyssen, V.; Tranchot-Diallo, J.; Parnet-Mathieu, F.; Lasfargues, G.; Courpotin, C.; Dormont, D. 1998: Neutralizing antibodies and complement-mediated, antibody-dependent enhancement (C'-ADE) of human immunodeficiency virus infection in its vertical transmission American Journal of Reproductive Immunology 39(6): 381-386
Boyer, V.; Desgranges, C.; Trabaud, M.A.; Fischer, E.; Kazatchkine, M.D. 1991: Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4- and antibody-independent fashion Journal of Experimental Medicine 173(5): 1151-1158
Tremblay, M.; Meloche, S.; Sekaly, R.P.; Wainberg, M.A. 1990: Complement receptor 2 mediates enhancement of human immunodeficiency virus 1 infection in Epstein-Barr virus-carrying B cells Journal of Experimental Medicine 171(5): 1791-1796
Kacani, L.; Stoiber, H.; Speth, C.; Bánki, Z.; Tenner-Racz, K.; Racz, P.; Dierich, M.P. 2001: Complement-dependent control of viral dynamics in pathogenesis of human immunodeficiency virus and simian immunodeficiency virus infection Molecular Immunology 38(2-3): 241-247
Yang, G-Bo.; Wang, Y.; Babaahmady, K.; Schøller, Jørgen.; Rahman, D.; Bunnik, E.; Spallek, R.; Zong, C-Miao.; Duan, J-Zhong.; Qin, C.; Jiang, H.; Singh, M.; Vaughan, R.; Bergmeier, L.A.; Schuitemaker, H.; Shao, Y.; Lehner, T. 2012: Immunization with recombinant macaque major histocompatibility complex class I and II and human immunodeficiency virus gp140 inhibits simian-human immunodeficiency virus infection in macaques Journal of General Virology 93(Pt 7): 1506-1518
Robinson, W.Edward. 2006: Mechanism for complement-mediated, antibody-dependent enhancement of human immunodeficiency virus type 1 infection in MT2 cells is enhanced entry through CD4, CD21, and CXCR4 chemokine receptors Viral Immunology 19(3): 434-447
Lund, O.; Hansen, J.; Søorensen, A.M.; Mosekilde, E.; Nielsen, J.O.; Hansen, J.E. 1995: Increased adhesion as a mechanism of antibody-dependent and antibody-independent complement-mediated enhancement of human immunodeficiency virus infection Journal of Virology 69(4): 2393-2400
Prohaszka, Z.; Prohasz, J.; Hidvegi, T.; Tegi, F.D.; Szabe, J.; Ujhelyi, E.; Thielens, N.; Dierich, M.P.; Kiss, J.; Arlaud, G.; Fust, G. 1996: Two parallel routes of the complement-dependent enhancement of the human immunodeficiency virus type I infection ELEVENTH INTERNATIONAL CONFERENCE ON AIDS Author Eleventh International Conference on AIDS, Vol One One world: One hope : 270
Aasa-Chapman, Mén.M.I.; Holuigue, S.; Aubin, K.; Wong, M.; Jones, N.A.; Cornforth, D.; Pellegrino, P.; Newton, P.; Williams, I.; Borrow, P.; McKnight, A. 2005: Detection of antibody-dependent complement-mediated inactivation of both autologous and heterologous virus in primary human immunodeficiency virus type 1 infection Journal of Virology 79(5): 2823-2830
Clapham, P.R.; Blanc, D.; Weiss, R.A. 1991: Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by Simian immunodeficiency virus Virology 181(2): 703-715
Spear, G.T.; Takefman, D.M.; Sullivan, B.L.; Landay, A.L.; Jennings, M.B.; Carlson, J.R. 1993: Anti-cellular antibodies in sera from vaccinated macaques can induce complement-mediated virolysis of human immunodeficiency virus and simian immunodeficiency virus Virology 195(2): 475-480
Kline, M.W.; Lewis, D.E.; Hollinger, F.B.; Reuben, J.M.; Hanson, L.C.; Kozinetz, C.A.; Dimitrov, D.H.; Rosenblatt, H.M.; Shearer, W.T. 1994: A comparative study of human immunodeficiency virus culture, polymerase chain reaction and anti-human immunodeficiency virus immunoglobulin A antibody detection in the diagnosis during early infancy of vertically acquired human immunodeficiency virus infection Pediatric Infectious Disease Journal 13(2): 90-94
Montefiori, D.C.; Murphey-Corb, M.; Desrosiers, R.C.; Daniel, M.D. 1990: Complement-mediated, infection-enhancing antibodies in plasma from vaccinated macaques before and after inoculation with live simian immunodeficiency virus Journal of Virology 64(10): 5223-5225
Clapham, P.R.; McKnight, A.; Weiss, R.A. 1992: Human immunodeficiency virus type 2 infection and fusion of CD4-negative human cell lines: induction and enhancement by soluble CD4 Journal of Virology 66(6): 3531-3537
Yaya, I.; Boyer, V.ér.; Ehlan, P.A.; Coulibaly, A.; Agboyibor, M.én.ég.K.; Traoré, I.; Kouamé, M.J.-B.; Maiga, A.K.; Kotchi, O.R.; Nyasenu, Y.T.; Maradan, G.ël.; Rojas-Castro, D.; Diallo, F.é; Anoma, C.; Dah, T.T.E.; Mensah, E.; Dembélé Keita, B.; Spire, B.; Dagnra, C.A.; Laurent, C.; Laurent, C.; Yaya, I.; Ouedraogo, S.; Granouillac, B.; Le Guicher, G.; Serrano, L.; Peeters, M.; Couderc, C.; Spire, B.; Sagaon-Teyssier, L.; Mora, M.; Maradan, G.ël.; Bourrelly, M.; Mimi, M.; Berenger, C.; Boyer, S.; Castro, D.R.; Riegel, L.; Palvadeau, P.él.; Keita, B.D.él.é; Diallo, F.é; Coulibaly, A.; Maïga, A.K.; Camara, D.; Diarra, M.; Ouologuem, A.; Sangaré, N.; Keita, A.A.; Cissé, O.; Traoré, F.é; Ouary, B.éh.A.; Kanta, I.; Anoma, C 2021: Heterogeneity in the Prevalence of High-Risk Human Papillomavirus Infection in Human Immunodeficiency Virus-Negative and Human Immunodeficiency Virus-Positive Men who have Sex with Men in West Africa Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 73(12): 2184-2192
Agrawal, A.; Goyal, A.; Goyal, S.; Kumari, S.; Singh, P.K. 2016: Seroprevalence of hepatitis B and syphilis co-infection in human immunodeficiency virus-positive antiretroviral therapy attendees and human immunodeficiency virus-negative sexually transmitted infection attendees Indian Journal of Sexually Transmitted Diseases and Aids 37(1): 94-95
Gras, G.; Richard, Y.; Roques, P.; Olivier, R.; Dormont, D. 1993: Complement and virus-specific antibody-dependent infection of normal B lymphocytes by human immunodeficiency virus type 1 Blood 81(7): 1808-1818
Matthai, S.M.; Valson, A.T.; Duhli, N.; Rupali, P.; Pulimood, A.B.; Varughese, S. 2018: Fibrillary glomerulonephritis in a human immunodeficiency virus-positive, hepatitis C-negative Indian patient: Expanding the profile of renal involvement in human immunodeficiency virus infection Indian Journal of Pathology and Microbiology 61(4): 610-613
Li, H.-R.; Cai, S.-X.; Chen, Y.-S.; Yu, M.-E.; Xu, N.-L.; Xie, B.-S.; Lin, M.; Hu, X.-L. 2016: Comparison of Talaromyces marneffei Infection in Human Immunodeficiency Virus-positive and Human Immunodeficiency Virus-negative Patients from Fujian, China Chinese Medical Journal 129(9): 1059-1065